List Results  
  Refine Search  
  Results by Topic  
  Results on Map  
  Search Details  
Found 12 studies with search of:   "Ceftazidime"
Hide studies that are not seeking new volunteers.
  Display Options
Rank Status Study
1 Completed Nebulized Ceftazidime and Amikacin in Ventilator Associated Pneumonia
Condition: Pneumonia
Interventions: Drug: ceftazidime and amikacin;   Drug: ceftazidime and amikacin
2 Not yet recruiting Ceftazidime Pharmacokinetic in Cerebrospinal Fluid Between Continuous and Intermittent Administration
Condition: Pseudomonas Aeruginosa Meningitis
Intervention: Drug: ceftazidime
3 Active, not recruiting Adverse Drug Reactions of Different Brands of Ceftazidime Injection
Condition: Infection
Intervention: Drug: ceftazidime
4 Recruiting A Randomized Double Blinded Comparison of Ceftazidime and Meropenem in Severe Melioidosis
Condition: Melioidosis
Interventions: Drug: Meropenem;   Drug: Ceftazidime
5 Terminated Continuous Versus Short Infusions of Ceftazidime in Cystic Fibrosis
Conditions: Cystic Fibrosis;   Pseudomonas Aeruginosa;   Pulmonary Exacerbation
Intervention: Drug: ceftazidime
6 Not yet recruiting Comparative Study of NXL104/Ceftazidime Versus Comparator in Adults With Complicated Urinary Tract Infections
Condition: Complicated Urinary Tract Infection
Interventions: Drug: NXL104/ceftazidime;   Drug: Imipenem/Cilastatin
7 Completed A Comparative Phase IV Study Evaluating Efficacy & Safety Of Magnex(Cefoperazone-Sulbactam) In Intraabdominal Infections
Condition: Infection
Interventions: Drug: Magnex (Sulbactam Sodium/Cefoperazone Sodium 1:1) Pfizer Ltd.;   Drug: Fortum (Ceftazidime for injection USP) Glaxo Smith Kline Pharmaceuticals Limited;   Drug: Metrogyl (Metronidazole Injection IP) J.B.Chemicals & Pharmaceuticals Ltd.;   Drug: Mikacin (Amikacin Sulphate Injection IP) Aristo Pharmaceuticals Ltd.
8 Not yet recruiting Prospective Multicenter Doubleblind Randomized Study of NXL104/Ceftazidime + Metronidazole vs. Meropenem in Treatment of Complicated Intra-Abdominal Infections
Condition: Complicated Intra-Abdominal Infections
Interventions: Drug: ceftazidime/NXL104 + metronidazole;   Drug: meropenem
9 Completed Standard vs. Biofilm Susceptibility Testing in Cystic Fibrosis (CF)
Conditions: Cystic Fibrosis;   Chronic Bronchitis
Interventions: Drug: IV amikacin;   Drug: PO azithromycin;   Drug: IV ceftazidime;   Drug: PO ciprofloxacin;   Drug: IV meropenem;   Drug: IV piperacillin-tazobactam;   Drug: IV ticarcillin-clavulanate;   Drug: IV tobramycin
10 Completed Prospective Randomized Evaluation of Antibiotic Regimen Following Appendectomy for Perforated Appendicitis
Condition: Perforated Appendicitis
Intervention: Drug: Ampicillin, gentamicin, clindamycin, flagyl, ceftazidime
11 Terminated Steady State Serum and Epithelial Lining Fluid (ELF) Antibiotics Concentrations Under Continous Infusion
Conditions: Pneumonia;   Bacteremia
Interventions: Drug: Meropenem;   Drug: Vancomycin;   Drug: Linezolid;   Drug: Piperacillin/Tazobactam;   Drug: Cefepim;   Drug: Ceftazidim
12 Recruiting Prolonging the Duration of Peripheral Venous Catheters in Cystic Fibrosis People
Conditions: Cystic Fibrosis;   Phlebitis
Interventions: Procedure: regular dilution of antibiotic in NS;   Procedure: higher dilution of antibiotic in NS

  RSS Feed for studies found by your search that were received in the last 14 days
  Download Options




U.S. National Library of Medicine,  Contact Help Desk
U.S. National Institutes of Health,  U.S. Department of Health & Human Services,
USA.gov,  Copyright,  Privacy,  Accessibility,  Freedom of Information Act

U.S. National Institutes of Health U.S. National Library of Medicine U.S. Department of Health & Human Services